Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (21 total)
-
Créateur: Anise N Happi, Chinedu A Ugwu, Christian T Happi
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-04-15
Description: This article discusses how "real-time genomic viral sequencing and surveillance of human populations represents a simple and cost-effective method of mitigating outbreaks in countries and locations that are most at risk of infectious disease… -
Créateur: Mbala-Kingebeni P, Aziza A, Di Paola N, Wiley MR, Makiala-Mandanda S, Caviness K, Pratt CB, Ladner JT, Kugelman JR, Prieto K, Chitty JA, Larson PA, Beitzel B, Ayouba A, Vidal N, Karhemere S, Diop M, Diagne MM, Faye M, Faye O, Aruna A, Nsio J, Mulangu…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-04-15
Description: The real-time generation of information about pathogen genomes has become a vital goal for transmission analysis and characterisation in rapid outbreak responses. In response to the recently established genomic capacity in the Democratic Republic of… -
Créateur: Fallah MP, Skrip LA.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-24
Description: This article reviews the testing of Ebola therapies during the outbreak. -
Créateur: National Institute of Allergy and Infectious Diseases (NIAID)
Sujet: Research
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2020-05-07
Description: This study is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adults diagnosed with COVID-19. The study is a multicenter trial that will be conducted in… -
Créateur: Boulware, David R., Matthew F. Pullen, Ananta S. Bangdiwala, Katelyn A. Pastick, Sarah M. Lofgren, Elizabeth C. Okafor, Caleb P. Skipper, Alanna A. Nascene, Melanie R. Nicol, Mahsa Abassi, Nicole W. Engen, Matthew P. Cheng, Derek LaBar, Sylvain A.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-08-06
Description: This reports on a randomized, double-blind, placebo-controlled trial across the United States and parts of Canada testing hydroxychloroquine as postexposure prophylaxis. -
Créateur: Furtado, Remo H. M., Otavio Berwanger, Henrique A. Fonseca, Thiago D. Corrêa, Leonardo R. Ferraz, Maura G. Lapa, Fernando G. Zampieri, Viviane C. Veiga, Luciano C. P. Azevedo, Regis G. Rosa, Renato D. Lopes, Alvaro Avezum, Airton L. O. Manoel, Felipe…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-09-08
Description: The efficacy and safety of azithromycin in the treatment of COVID-19 remain uncertain. We assessed whether adding azithromycin to standard of care, which included hydroxychloroquine, would improve clinical outcomes of patients admitted to the… -
Créateur: WHO Solidarity Trial Consortium
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-12-02
Description: World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19). -
Créateur: Ella, Raches, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-08
Description: BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 μg or 6 μg) formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum (Algel). We previously reported findings from a double-blind, multicentre, randomised, controlled… -
Créateur: University of Minnesota, Center for Infectious Disease Research and Policy
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2017-01-17
Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced. -
Créateur: the ACTT-1 Study Group Members
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2020-05-22
Description: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement."